Clinical Trial Update: Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetics, safety, and tolerability of ATM-AVI for complicated intra-abdominal infections in hospitalized adults; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infections

Drugs mentioned

• ATM-AVI

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-Abdominal Infections, cIAIs | Phase 2 | Status: COMPLETED | Results posted: 2019-03-04